A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma.
Saved in:
| Title: | A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. |
|---|---|
| Authors: | Younes, A.1 ayounes@mdanderson.org, Vose, J. M.2, Zelenetz, A. D.3, Smith, M. R.4, Burris, H. A.5, Ansell, S. M.6, Klein, J.7, Halpern, W.8, Miceli, R.7, Kumm, E.7, Fox, N. L.7, Czuczman, M. S.9 |
| Source: | British Journal of Cancer. 12/7/2010, Vol. 103 Issue 12, p1783-1787. 5p. 2 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 55659386 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Younes%2C+A%2E%22">Younes, A.</searchLink><relatesTo>1</relatesTo><i> ayounes@mdanderson.org</i><br /><searchLink fieldCode="AR" term="%22Vose%2C+J%2E+M%2E%22">Vose, J. M.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Zelenetz%2C+A%2E+D%2E%22">Zelenetz, A. D.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Smith%2C+M%2E+R%2E%22">Smith, M. R.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Burris%2C+H%2E+A%2E%22">Burris, H. A.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Ansell%2C+S%2E+M%2E%22">Ansell, S. M.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Klein%2C+J%2E%22">Klein, J.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Halpern%2C+W%2E%22">Halpern, W.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Miceli%2C+R%2E%22">Miceli, R.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Kumm%2C+E%2E%22">Kumm, E.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Fox%2C+N%2E+L%2E%22">Fox, N. L.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Czuczman%2C+M%2E+S%2E%22">Czuczman, M. S.</searchLink><relatesTo>9</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Cancer%22">British Journal of Cancer</searchLink>. 12/7/2010, Vol. 103 Issue 12, p1783-1787. 5p. 2 Charts, 2 Graphs. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=55659386 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/sj.bjc.6605987 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 5 StartPage: 1783 Titles: – TitleFull: A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Younes, A. – PersonEntity: Name: NameFull: Vose, J. M. – PersonEntity: Name: NameFull: Zelenetz, A. D. – PersonEntity: Name: NameFull: Smith, M. R. – PersonEntity: Name: NameFull: Burris, H. A. – PersonEntity: Name: NameFull: Ansell, S. M. – PersonEntity: Name: NameFull: Klein, J. – PersonEntity: Name: NameFull: Halpern, W. – PersonEntity: Name: NameFull: Miceli, R. – PersonEntity: Name: NameFull: Kumm, E. – PersonEntity: Name: NameFull: Fox, N. L. – PersonEntity: Name: NameFull: Czuczman, M. S. IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 12 Text: 12/7/2010 Type: published Y: 2010 Identifiers: – Type: issn-print Value: 00070920 Numbering: – Type: volume Value: 103 – Type: issue Value: 12 Titles: – TitleFull: British Journal of Cancer Type: main |
| ResultId | 1 |
